Leerink Partners Maintains Dentsply Sirona(XRAY.US) With Buy Rating
Leerink Partners analyst Michael Cherny maintains $Dentsply Sirona(XRAY.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 50.0% and a total average return of 2.9%
DENTSPLY SIRONA (XRAY) Receives a Buy From Leerink Partners
DENTSPLY SIRONA Stock May Gain on the Launch of Primescan 2
Clear Aligner Market Insights & Forecast Report 2024-2028, Featuring Company Profiles of Dentsply Sirona, Align Technology, Envista Holdings, Straumann Holding and SmileDirectClub - ResearchAndMarkets.com
Dentsply Sirona Presents Primescan 2 Powered by DS Core: The First Cloud-native Intraoral Scanning Solution
With Earnings Season Behind Us, the Stock Market Is Aiming at a Breakout